Literature DB >> 8279622

Mucinous meningioma. Report of an unusual variant of meningioma that may mimic metastatic mucin-producing carcinoma.

M Berho1, S Suster.   

Abstract

An unusual variant of meningioma is described that was characterized by small clusters and strands of meningothelial cells surrounded by abundant mucinous stroma. The unusual appearance of the lesion prompted an initial diagnosis of metastatic mucin-secreting carcinoma (so-called colloid carcinoma) resulting in extensive clinical evaluation in search for a primary. Histochemical studies showed the mucinous material to be composed of strongly sulfated acid mucopolysaccharides rich in hyaluronic acid. Immunohistochemical studies showed strong membrane staining of the tumor cells with epithelial membrane antigen and positive cytoplasmic staining with vimentin antibodies. Ultrastructural examination revealed the characteristic features of meningothelial cells (i.e., abundant long, interdigitating cytoplasmic processes joined by well-developed cell junctions) but failed to demonstrate secretory activity within the neoplastic cells. The prominent mucinous stroma in this case most probably represents a nonspecific reaction of stromal cells to an undetermined stimulus. Mucinous meningioma should be added to the list of morphologic variants of meningioma and should be considered in the differential diagnosis of mucinous lesions in intracranial locations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8279622

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  2 in total

1.  Atypical carcinoid with prominent mucinous stroma: a hitherto unreported variant of pulmonary neuroendocrine tumor.

Authors:  Nazarena Nannini; Federica Bertolini; Alberto Cavazza; Christian Casali; Maria Cecilia Mengoli; Giulio Rossi
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

Review 2.  Pathology and molecular genetics of meningioma: recent advances.

Authors:  Makoto Shibuya
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-12-20       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.